Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Breathing-Controlled Electrical Stimulation for Hand Recovery After Stroke

Tests breathing-controlled electrical stimulation to ease hand stiffness in adults with chronic stroke.

Plain-language title generated from the registry record
Registry title: BreEStim for Motor Recovery in Chronic Stroke With Severe Impairment (Pilot)

Key facts

Where
Houston, United StatesSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 75 years old?

Source: NCT04750564, who can take part

Where in United States

  • The University of Texas Health Science CenterHouston, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
The University of Texas Health Science Center, Houston
Trial code
NCT04750564
Record updated
3 June 2026
Original description
The overall goal is to investigate the effectiveness of a novel intervention - Breathing-controlled electrical stimulation (BreEStim) on finger flexor spasticity reduction and hand function improvement in chronic stroke with severe impairment.Read full original descriptionShow less

BreEStim for Post-Stroke Motor Recovery

The overall goal is to investigate the effectiveness of a novel intervention - Breathing-controlled electrical stimulation (BreEStim) on finger flexor spasticity reduction and hand function improvement in chronic stroke with severe impairment.

Inclusion: has post stroke ≥ 6 months , medically stable; Unilateral, single stroke (no restriction on type (ischemic or hemorrhagic) or volume (large or small) of stroke); MAS score ≥ 1, i.e., detectable finger flexor hypertonia.

Exclusion: Patients that are currently adjusting tone alternating medications (e.g., baclofen), or; Patients received botulinum toxin injection to the arm/fingers <4 months, or phenol injections < 2 years; Patients with visual deficit/neglect; hearing or cognitive impairment; Patients with history of pulmonary disease (Asthma, chronic obstruction pulmonary disease, COPD); Patients with a pacemaker; Women who are pregnant.

ClinicalTrials.gov NCT04750564